11/15
08:04 am
crgx
CARGO Therapeutics, Inc. (NASDAQ: CRGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
Medium
Report
CARGO Therapeutics, Inc. (NASDAQ: CRGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
11/13
05:47 pm
crgx
CARGO Therapeutics, Inc. (NASDAQ: CRGX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
High
Report
CARGO Therapeutics, Inc. (NASDAQ: CRGX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
11/12
04:05 pm
crgx
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
11/5
04:05 pm
crgx
CARGO Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
CARGO Therapeutics to Participate in Upcoming Investor Conferences
11/5
09:23 am
crgx
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
High
Report
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity